BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26038529)

  • 21.
    Chen TK; Appel LJ; Grams ME; Tin A; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1765-1769. PubMed ID: 28572159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. African American living-kidney donors should be screened for APOL1 risk alleles.
    Cohen DM; Mittalhenkle A; Scott DL; Young CJ; Norman DJ
    Transplantation; 2011 Oct; 92(7):722-5. PubMed ID: 21878839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy.
    Larsen CP; Beggs ML; Saeed M; Walker PD
    J Am Soc Nephrol; 2013 Apr; 24(5):722-5. PubMed ID: 23520206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy.
    Divers J; Núñez M; High KP; Murea M; Rocco MV; Ma L; Bowden DW; Hicks PJ; Spainhour M; Ornelles DA; Kleiboeker SB; Duncan K; Langefeld CD; Turner J; Freedman BI
    Kidney Int; 2013 Dec; 84(6):1207-13. PubMed ID: 23677244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOL1 G1 genotype modifies the association between HDLC and kidney function in African Americans.
    Bentley AR; Divers J; Shriner D; Doumatey AP; Gutiérrez OM; Adeyemo AA; Freedman BI; Rotimi CN
    BMC Genomics; 2015 May; 16(1):421. PubMed ID: 26025194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.
    Kopp JB; Nelson GW; Sampath K; Johnson RC; Genovese G; An P; Friedman D; Briggs W; Dart R; Korbet S; Mokrzycki MH; Kimmel PL; Limou S; Ahuja TS; Berns JS; Fryc J; Simon EE; Smith MC; Trachtman H; Michel DM; Schelling JR; Vlahov D; Pollak M; Winkler CA
    J Am Soc Nephrol; 2011 Nov; 22(11):2129-37. PubMed ID: 21997394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histopathologic findings associated with APOL1 risk variants in chronic kidney disease.
    Larsen CP; Beggs ML; Saeed M; Ambruzs JM; Cossey LN; Messias NC; Walker PD; Freedman BI
    Mod Pathol; 2015 Jan; 28(1):95-102. PubMed ID: 25081748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards a definition of glomerulomegaly: clinical-pathological and methodological considerations.
    Hughson MD; Hoy WE; Douglas-Denton RN; Zimanyi MA; Bertram JF
    Nephrol Dial Transplant; 2011 Jul; 26(7):2202-8. PubMed ID: 21115671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Target organ damage in African American hypertension: role of APOL1.
    Freedman BI; Murea M
    Curr Hypertens Rep; 2012 Feb; 14(1):21-8. PubMed ID: 22068337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertension, glomerular hypertrophy and nephrosclerosis: the effect of race.
    Hughson MD; Puelles VG; Hoy WE; Douglas-Denton RN; Mott SA; Bertram JF
    Nephrol Dial Transplant; 2014 Jul; 29(7):1399-409. PubMed ID: 24327566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. APOL1 Genotype and Race Differences in Incident Albuminuria and Renal Function Decline.
    Peralta CA; Bibbins-Domingo K; Vittinghoff E; Lin F; Fornage M; Kopp JB; Winkler CA
    J Am Soc Nephrol; 2016 Mar; 27(3):887-93. PubMed ID: 26180129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic variation in APOL1 associates with younger age at hemodialysis initiation.
    Kanji Z; Powe CE; Wenger JB; Huang C; Ankers E; Sullivan DA; Collerone G; Powe NR; Tonelli M; Bhan I; Bernhardy AJ; Dibartolo S; Friedman D; Genovese G; Pollak MR; Thadhani R
    J Am Soc Nephrol; 2011 Nov; 22(11):2091-7. PubMed ID: 21997398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.
    Lipkowitz MS; Freedman BI; Langefeld CD; Comeau ME; Bowden DW; Kao WH; Astor BC; Bottinger EP; Iyengar SK; Klotman PE; Freedman RG; Zhang W; Parekh RS; Choi MJ; Nelson GW; Winkler CA; Kopp JB;
    Kidney Int; 2013 Jan; 83(1):114-20. PubMed ID: 22832513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.
    Freedman BI; Pastan SO; Israni AK; Schladt D; Julian BA; Gautreaux MD; Hauptfeld V; Bray RA; Gebel HM; Kirk AD; Gaston RS; Rogers J; Farney AC; Orlando G; Stratta RJ; Mohan S; Ma L; Langefeld CD; Bowden DW; Hicks PJ; Palmer ND; Palanisamy A; Reeves-Daniel AM; Brown WM; Divers J
    Transplantation; 2016 Jan; 100(1):194-202. PubMed ID: 26566060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics.
    Atta MG; Estrella MM; Kuperman M; Foy MC; Fine DM; Racusen LC; Lucas GM; Nelson GW; Warner AC; Winkler CA; Kopp JB
    Kidney Int; 2012 Aug; 82(3):338-43. PubMed ID: 22495294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.
    Beckerman P; Bi-Karchin J; Park AS; Qiu C; Dummer PD; Soomro I; Boustany-Kari CM; Pullen SS; Miner JH; Hu CA; Rohacs T; Inoue K; Ishibe S; Saleem MA; Palmer MB; Cuervo AM; Kopp JB; Susztak K
    Nat Med; 2017 Apr; 23(4):429-438. PubMed ID: 28218918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined Effects of GSTM1 Null Allele and APOL1 Renal Risk Alleles in CKD Progression in the African American Study of Kidney Disease and Hypertension Trial.
    Bodonyi-Kovacs G; Ma JZ; Chang J; Lipkowitz MS; Kopp JB; Winkler CA; Le TH
    J Am Soc Nephrol; 2016 Oct; 27(10):3140-3152. PubMed ID: 26940095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glomerular Effects of Age and APOL1.
    Meyer TW; Lenihan CR
    J Am Soc Nephrol; 2015 Dec; 26(12):2901-3. PubMed ID: 26038527
    [No Abstract]   [Full Text] [Related]  

  • 39. Collapsing glomerulopathy associated lupus in a black female with homozygous APOL1 mutation.
    Kofman T; Narjoz C; Raimbourg Q; Loriot MA; Karras A; Roland M; Hill G; Jacquot C; Nochy D; Thervet E
    Lupus; 2012 Nov; 21(13):1459-62. PubMed ID: 22952321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.
    Ma L; Langefeld CD; Comeau ME; Bonomo JA; Rocco MV; Burkart JM; Divers J; Palmer ND; Hicks PJ; Bowden DW; Lea JP; Krisher JO; Clay MJ; Freedman BI
    Kidney Int; 2016 Aug; 90(2):389-395. PubMed ID: 27157696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.